Acetylcholine-induced systemic vasodilation resistant to N(G)-nitro-L-arginine in anaesthetized rats

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 7-8, 1998, Pages 510-516

  Kakizoe, Eiichi ^a   Wang, Dan Qiao ^a   Kobayashi, Yuta ^a   Shimoura, Keiko ^a   Okunishi, Hideki ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Area over the pressure curve; Endothelium derived hyperpolarizing factor; Half recovery time; Metyrapone; Nitric oxide; Nitric oxide synthase inhibitor

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; METYRAPONE; N(G) NITROARGININE; NITRIC OXIDE; PHENYLEPHRINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; DEPRESSOR RESPONSE; ENDOTHELIUM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASODILATATION;

EID: 0031827495     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02244.x     Document Type: Article

References (31)

1. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 1984; 24: 175-97.
2. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties identical to those of nitric oxide radical. Circ. Res. 1987; 61: 866-79.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
4. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 1988; 153: 1251-6.
5. Schmidt HHHW, Klein MK, Niroomand F, B hme E. Is arginine a physiological precursor of endothelium-derived nitric oxide? Eur. J. Pharmacol. 1988; 148: 293-5.
6. Kobayashi Y, Hattori K. Nitroarginine inhibits endothelium-derived relaxation. Jpn. J. Pharmacol. 1990; 52: 167-9.
7. 5-[imino (nitroamino)-methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1990; 341: 143-7.
8. G-Nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br. J. Pharmacol. 1990; 99: 408-12.
9. Richard V, Tanner FC, Tschudi M, Lüscher TF. Different activation of L-arginine pathway by bradykinin, serotonin. and clonidine in coronary arteries. Am. J. Physiol. 1990; 259: H1433-9.
10. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl Acad. Sci. USA 1989; 86: 3375-8.
11. Manning RD Jr, Hu L, Mizelle HL, Montani J-P, Norton MW. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension 1993; 22: 40-8.
12. Aisaka K, Gross SS, Griffith OW, Levi R. L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem. Biophys. Res. Commun. 1989; 163: 710-17.
13. Whittle BJR, Lopez-Belmonte J, Rees DD. Modulation of the vasode-pressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 1989; 98: 646-52.
14. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 1990; 101: 746-52.
15. G-nitro-L-arginine in rat aorta. Eur. J. Pharmacol. 1995; 274: 25-32.
16. Lischke V, Busse R, Hecker M. Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br. J. Pharmacol. 1995; 115: 969-74.
17. 2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br. J. Pharmacol. 1997; 120: 695-701.
18. + channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries. J. Physiol. 1995; 489: 723-34.
19. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of the endothelium-derived hyperpolarizing factor released from coronary arteries as a cytochrome P450-derived arachidonic acid metabolite. J. Physiol. 1994; 481: 407-14.
20. Fulton D, Mahboubi K, McGiff JC, Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 1995; 114: 99-102.
21. Murray M, Reidy GF. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 1990; 42: 85-101.
22. LaBella FS. Cytochrome P450 enzymes: Ubiquitous 'receptors' for drugs. Can. J. Physiol Pharmacol. 1991; 69: 1129-32.
23. G-monomethyl-L-arginine in SHRSP. Jpn. J. Pharmacol. 1990; 54: 461-3.
24. Kobayashi Y, Ikeda K, Shinozuka K, Nara Y, Yamori Y, Hattori K. L-Nitroarginine increases blood pressure in the rat. Clin. Exp. Pharmacol. Physiol. 1991; 18: 397-9.
25. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun. 1989; 160: 881-6.
26. Philp RB, Paul ML. Effect of aspirin dosage and time of administration on arterial prostacyclin and platelet aggregation in rats. Prostaglandins Leukot. Med. 1984; 15: 91-102.
27. Fantuzzi G, Cantoni L, Sironi M, Ghezzi P. Inhibitors of cytochrome P450 suppress tumor necrosis factor production. Cell. Immunol. 1993; 150: 417-24.
28. Walters E, Buchheit K, Maruniak JA. Olfactory cytochrome P-450 immunoreactivity in mice is altered by dichlobenil but preserved by metyrapone. Toxicology 1993; 81: 113-22.
29. Potmis RA, Nonavinakere VK, Rasekh HR, Early JL II. Effect of selenium (Se) on plasma ACTH, β-endorphin, corticosterone and glucose in rat: Influence of adrenal enucleation and metyrapone pretreatment. Toxicology 1993; 79: 1-9.
30. Vanhoutte PM. Choltnergic inhibition of adrenergic transmission. Fed. Proc. 1977; 36: 2444-9.
31. Brayden JE, Bevan JA. Neurogenic muscarinic vasodilation in the cat. An example of endothelial cell-independent cholinergic relaxation. Circ. Res. 1985; 56: 205-11.